Kidney Antibody
Kidney Antibody
![]() Kidney Lysate |
|||
21-116 | ProSci | 0.1 mg | 342.6 EUR |
Description: Guinea Pig kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The guinea pig kidney tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
![]() Kidney Lysate |
|||
21-190 | ProSci | 0.1 mg | 342.6 EUR |
Description: Monkey (Cynomolgus) kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Cynomolgus) kidney tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
![]() Kidney Lysate |
|||
21-405 | ProSci | 0.1 mg | 342.6 EUR |
Description: Porcine kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The porcine kidney tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
![]() Kidney Lysate |
|||
21-418 | ProSci | 0.1 mg | 342.6 EUR |
Description: Rabbit kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The rabbit kidney tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
![]() Mouse Kidney PrimaCell2: Normal Kidney Epithelial Cells |
|||
2-82057 | CHI Scientific | 1 Kit | Ask for price |
![]() Rat Kidney PrimaCell2: Normal Kidney Epithelial Cells |
|||
2-82556 | CHI Scientific | 1 Kit | Ask for price |
![]() Human Kidney PrimaCell2: Normal Kidney Epithelial Cells |
|||
2-96075 | CHI Scientific | 1 Kit | Ask for price |
![]() Multiple kidney tumor with kidney tissue array |
|||
KD1501a | TissueArray | each | 258 EUR |
Description: Multiple kidney tumor with kidney tissue array, including pathology grade, TNM and clinical stage (reference AJCC 7th version), 75 cases/150 cores, replacing KD1501 |
|||
![]() Kidney carcinoma with matched kidney tissue array |
|||
KD244a | TissueArray | each | 48 EUR |
Description: Kidney carcinoma with matched kidney tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing KD244 |
|||
![]() Kidney cancer with matched kidney tissue array |
|||
KD801a | TissueArray | each | 258 EUR |
Description: Kidney cancer with matched kidney tissue array, including pathology grade, TNM and clinical stagr, 40 cases/80 cores, replacing KD801 |
|||
![]() Kidney disease spectrum (kidney cancer progression) tissue array |
|||
BC07001 | TissueArray | each | 258 EUR |
Description: Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases/80 cores (core size 1.5mm) |
|||
![]() Kidney cancer tissue array with normal Kidney tissue |
|||
KD2082a | TissueArray | each | 474 EUR |
Description: Kidney cancer tissue array with normal Kidney tissue, including TNM and pathology grade, 96 cases/192 cores, replacing KD2082 |
|||
![]() Multiple kidney cancer with matched kidney tissue array |
|||
KD461 | TissueArray | each | 258 EUR |
Description: Multiple kidney cancer with matched kidney tissue array, including pathology grade, TNM and clinical stage, 23 cases/46 cores |
|||
![]() Normal kidney and normal adjacent kidney tissue array |
|||
KDN241a | TissueArray | each | 138 EUR |
Description: Normal kidney and normal adjacent kidney tissue array, 24 cases/ 24 cores |
|||
![]() Kidney cancer with kidney tissue test tissue array |
|||
T071b | TissueArray | each | 48 EUR |
Description: Kidney cancer with kidney tissue test tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T071a |
|||
![]() Kidney Lupus Lysate |
|||
XBL-10357 | ProSci | 0.1 mg | 796.2 EUR |
Description: Human kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human kidney tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
![]() Fetal Kidney Lysate |
|||
XBL-10408 | ProSci | 0.1 mg | 342.6 EUR |
Description: Fetal human kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human kidney tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
![]() Kidney Membrane Lysate |
|||
XBL-10649 | ProSci | 0.1 mg | 619.8 EUR |
Description: Human kidney tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human kidney tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated kidney tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated kidney tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
![]() Kidney cancer (CCRCC |
|||
KD1201 | TissueArray | each | 306 EUR |
Description: Kidney cancer (CCRCC,PRCC,CRCC)with kidney tissue array,including ISUP Grade, TNM/Stage, 120 cases/120 cores (core size 1.0mm ), (Previous Item# is BC07115b) |
|||
![]() Kidney tissue array |
|||
KD803b | TissueArray | each | 354 EUR |
Description: Kidney tissue array, 80 cases/80n cores (core size 1.5mm), replacing KD803a |
|||
![]() Human Kidney CAFs |
|||
CAF110 | Neuromics | 1,000,000 cells | Ask for price |
![]() Rat Kidney PrimaCell2: Normal Kidney Epithelial Cells Growth Medium |
|||
9-25056 | CHI Scientific | 5 x 100 ml | Ask for price |
![]() Mouse Kidney PrimaCell2: Normal Kidney Epithelial Cells Growth Medium |
|||
9-32057 | CHI Scientific | 5 x 100 ml | Ask for price |
![]() Human Kidney PrimaCell2: Normal Kidney Epithelial Cells Growth Medium |
|||
9-46075 | CHI Scientific | 5 x 100 ml | Ask for price |
![]() Kidney cancer tissue array with adjacent normal kidney tissue |
|||
BC07015b | TissueArray | each | 168 EUR |
Description: Kidney cancer tissue array with adjacent normal kidney tissue, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC07015a |
|||
![]() Kidney cancer with matched adjacent normal kidney tissue array |
|||
KD603 | TissueArray | each | 204 EUR |
Description: Kidney cancer with matched adjacent normal kidney tissue array, containing metastatic clear cell carcinoma, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/61 cores |
|||
![]() alkaline phosphatase (liver/bone/kidney) antibody |
|||
22964-100ul | SAB | 100ul | 468 EUR |
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx132288 | Abbexa |
|
|
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx102457 | Abbexa |
|
|
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx102458 | Abbexa |
|
|
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx102460 | Abbexa |
|
|
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx131127 | Abbexa |
|
|
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx131128 | Abbexa |
|
|
![]() Kidney And Brain Protein (KIBRA) Antibody |
|||
20-abx131689 | Abbexa |
|
|
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx270135 | Abbexa |
|
|
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx270177 | Abbexa |
|
|
![]() Glutaminase Kidney Isoform, Mitochondrial (GLS) Antibody |
|||
abx234518-100ug | Abbexa | 100 ug | 577.2 EUR |
![]() Glutaminase Kidney Isoform, Mitochondrial (GLS) Antibody |
|||
abx234519-100ug | Abbexa | 100 ug | 610.8 EUR |
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx173255 | Abbexa |
|
|
![]() Kidney And Brain Protein (KIBRA) Antibody |
|||
20-abx177265 | Abbexa |
|
|
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx177266 | Abbexa |
|
|
![]() Kidney Injury Molecule 1 (Kim1) Antibody |
|||
20-abx177267 | Abbexa |
|
|
![]() Human Kidney Tissue Preparation Buffer 2: Normal Kidney Epithelial Cells |
|||
9-80075 | CHI Scientific | 1 x 100 ml | Ask for price |
![]() Mouse Kidney Tissue Preparation Buffer 2: Normal Kidney Epithelial Cells |
|||
9-80171 | CHI Scientific | 1 x 100 ml | Ask for price |
![]() Rat Kidney Tissue Preparation Buffer 2: Normal Kidney Epithelial Cells |
|||
9-80263 | CHI Scientific | 1 x 100 ml | Ask for price |
![]() Kidney cancer tissue array with matched cancer adjacent kidney tissue |
|||
KD2601a | TissueArray | each | 354 EUR |
Description: Kidney cancer tissue array with matched cancer adjacent kidney tissue,including TNM, clinical stage and pathology grade, 65 cases/ 260 cores, replacing KD2061 |
|||
![]() Kidney tumor tissue array with matched tumor adjacent kidney tissue |
|||
KD2602a | TissueArray | each | 354 EUR |
Description: Kidney tumor tissue array with matched tumor adjacent kidney tissue, including TNM, clinical stage and pathology grade, 65 cases/260 cores, replacing KD2602 |
|||
![]() Kidney clear cell carcinoma with matched adjacent kidney tissue array |
|||
KD486 | TissueArray | each | 168 EUR |
Description: Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases/48 cores |
|||
![]() Kidney cancer tissue array with matched adjacent normal kidney tissue |
|||
KD901a | TissueArray | each | 258 EUR |
Description: Kidney cancer tissue array with matched adjacent normal kidney tissue, including TNM, clinical stage and pathology grade, 40 cases/90 cores, replacing KD901 |
|||
![]() Kidney Tissue Slide (Normal) |
|||
10-401-10um | ProSci | 10 um | 241.8 EUR |
![]() Kidney Tissue Slide (Normal) |
|||
10-401-4um | ProSci | 4 um | 216.6 EUR |
![]() Kidney Tissue Slide (Tumor) |
|||
10-402-10um | ProSci | 10 um | 241.8 EUR |
![]() Kidney Tissue Slide (Tumor) |
|||
10-402-4um | ProSci | 4 um | 216.6 EUR |
![]() Kidney Tissue Slide (Abnormal) |
|||
10-455-10um | ProSci | 10 um | 241.8 EUR |
![]() Kidney Tissue Slide (Abnormal) |
|||
10-455-4um | ProSci | 4 um | 216.6 EUR |
![]() Human Kidney Tissue Lysate |
|||
30R-AK003 | Fitzgerald | 150 ug | 262.8 EUR |
Description: Fresh tissue lysate isolated from human kidney |
|||
![]() Kidney Tissue Lysate (Normal) |
|||
1706-02 | ProSci | 0.1 mg | 260.7 EUR |
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Normal) |
|||
1706-03 | ProSci | 0.1 mg | 260.7 EUR |
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Normal) |
|||
1706-04 | ProSci | 0.1 mg | 260.7 EUR |
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Normal) |
|||
1706-05 | ProSci | 0.1 mg | 260.7 EUR |
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1707-01 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1707-02 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1707-03 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1707-04 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1707-05 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1707-06 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1707-07 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1707-08 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1707-09 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1708-01 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1708-02 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
![]() Kidney Tissue Lysate (Tumor) |
|||
1708-03 | ProSci | 0.1 mg | 336.3 EUR |
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |